Jaguar Health Inc (NASDAQ:JAGX)
| 0.357 Delayed Data As of Nov 30 |  +0.0034 / +0.97%Today’s Change | 0.21 Today|||52-Week Range 11.40 | -94.52% Year-to-Date |
Latest JAGX News | Press Releases
No recent news for Jaguar Health Inc.
Today’s Trading
| Previous close | 0.35 |
| Today’s open | 0.36 |
| Day’s range | 0.35 - 0.38 |
| Volume | 2,080,299 |
| Average volume (3 months) | 3,722,445 |
| Market cap | $17.8M |
Data as of 3:49pm ET, 11/30/2023
Growth & Valuation
| Earnings growth (last year) | +58.99% |
| Earnings growth (this year) | +83.89% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | +175.80% |
| P/E ratio | NM |
| Price/Sales | 0.71 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MBRXMoleculin Biotech In... | +0.02 | +4.12% |
| DRRXDURECT Corp | -0.03 | -4.62% |
| SSKNSTRATA Skin Sciences... | +0.03 | +6.40% |
| NRBONeurobo Pharmaceutic... | +0.02 | +4.19% |
Data as of 3:59pm ET, 11/30/2023
Financials
| Next reporting date | April 9, 2024 |
| EPS forecast (this quarter) | -$0.98 |
| Annual revenue (last year) | $12.0M |
| Annual profit (last year) | -$47.5M |
| Net profit margin | -396.91% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Francisco, California |
Forecasts
